(14) reported that NELFE is an oncogenic protein that may cause transcriptome imbalance in hepatocellular carcinoma (HCC) by regulating MYC signaling and the NELFE-dependent MYC target (NDMT) gene signature to predict a unique subtype of HCC. This evidence concerns the gene NELFE and hepatocellular carcinoma.